Cargando…

Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons

INTRODUCTION: Coverage of essential prevention and control services and adequate monitoring schemes for viral hepatitis are often suboptimal in prison settings. Yet, evidence shows that targeted interventions are feasible and effective in reducing viral hepatitis burden and decreasing virus circulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyler, T, Montanari, L, Ceccarelli, L, Torri, E, Mazzilli, S, Tavoschi, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594475/
http://dx.doi.org/10.1093/eurpub/ckac129.387
_version_ 1784815428703354880
author Seyler, T
Montanari, L
Ceccarelli, L
Torri, E
Mazzilli, S
Tavoschi, L
author_facet Seyler, T
Montanari, L
Ceccarelli, L
Torri, E
Mazzilli, S
Tavoschi, L
author_sort Seyler, T
collection PubMed
description INTRODUCTION: Coverage of essential prevention and control services and adequate monitoring schemes for viral hepatitis are often suboptimal in prison settings. Yet, evidence shows that targeted interventions are feasible and effective in reducing viral hepatitis burden and decreasing virus circulation among people living in prison and the community at large. To promote transferability and improvement of prison health quality in EU/EEA the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) will identify and disseminate models of care for viral hepatitis elimination in prisons. METHODS: The models of care were gathered using a data collection tool that has been designed for this purpose based on the literature review and agreed with an expert advisory group. Based on the results of the data collection, a survey for healthcare staff working in 5 selected prison institutions in the EU/EEA has been developed. RESULTS: The following models of care were collected: HCV micro-elimination in prison; transitional care for HCV treatment or HBV prevention/treatment; HCV or HBV care services tailored to women living in prison; HBV or HAV/HBV vaccination in prison settings. Harm reduction and drug treatment services in the prison are essential at all steps of the prevention and continuum of care. Among barriers identified were: engagement of people living in prison and prison governance structure, availability of infrastructural and human resources, daily prison organisation, inter-sectorial collaboration within prison and between prison and community services, training for prison staff and lack of systematic monitoring. CONCLUSIONS: Evidence of effective and acceptable interventions in prison to prevent and control viral hepatitis is essential to foster inclusion of prison setting within national elimination programmes. Intra-EU benchmarking may help promote awareness, to allocate adequate resources, monitor of impact and ultimately the achievement of the elimination goal.
format Online
Article
Text
id pubmed-9594475
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95944752022-11-22 Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons Seyler, T Montanari, L Ceccarelli, L Torri, E Mazzilli, S Tavoschi, L Eur J Public Health Parallel Programme INTRODUCTION: Coverage of essential prevention and control services and adequate monitoring schemes for viral hepatitis are often suboptimal in prison settings. Yet, evidence shows that targeted interventions are feasible and effective in reducing viral hepatitis burden and decreasing virus circulation among people living in prison and the community at large. To promote transferability and improvement of prison health quality in EU/EEA the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) will identify and disseminate models of care for viral hepatitis elimination in prisons. METHODS: The models of care were gathered using a data collection tool that has been designed for this purpose based on the literature review and agreed with an expert advisory group. Based on the results of the data collection, a survey for healthcare staff working in 5 selected prison institutions in the EU/EEA has been developed. RESULTS: The following models of care were collected: HCV micro-elimination in prison; transitional care for HCV treatment or HBV prevention/treatment; HCV or HBV care services tailored to women living in prison; HBV or HAV/HBV vaccination in prison settings. Harm reduction and drug treatment services in the prison are essential at all steps of the prevention and continuum of care. Among barriers identified were: engagement of people living in prison and prison governance structure, availability of infrastructural and human resources, daily prison organisation, inter-sectorial collaboration within prison and between prison and community services, training for prison staff and lack of systematic monitoring. CONCLUSIONS: Evidence of effective and acceptable interventions in prison to prevent and control viral hepatitis is essential to foster inclusion of prison setting within national elimination programmes. Intra-EU benchmarking may help promote awareness, to allocate adequate resources, monitor of impact and ultimately the achievement of the elimination goal. Oxford University Press 2022-10-25 /pmc/articles/PMC9594475/ http://dx.doi.org/10.1093/eurpub/ckac129.387 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Parallel Programme
Seyler, T
Montanari, L
Ceccarelli, L
Torri, E
Mazzilli, S
Tavoschi, L
Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons
title Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons
title_full Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons
title_fullStr Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons
title_full_unstemmed Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons
title_short Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons
title_sort viral hepatitis micro-elimination: models of care and barriers to implementation in 5 eu/eea prisons
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594475/
http://dx.doi.org/10.1093/eurpub/ckac129.387
work_keys_str_mv AT seylert viralhepatitismicroeliminationmodelsofcareandbarrierstoimplementationin5eueeaprisons
AT montanaril viralhepatitismicroeliminationmodelsofcareandbarrierstoimplementationin5eueeaprisons
AT ceccarellil viralhepatitismicroeliminationmodelsofcareandbarrierstoimplementationin5eueeaprisons
AT torrie viralhepatitismicroeliminationmodelsofcareandbarrierstoimplementationin5eueeaprisons
AT mazzillis viralhepatitismicroeliminationmodelsofcareandbarrierstoimplementationin5eueeaprisons
AT tavoschil viralhepatitismicroeliminationmodelsofcareandbarrierstoimplementationin5eueeaprisons